Salcaprozate Impurity 3
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

287935-37-9Salcaprozate Impurity 3

● Auf Lager

Katalog-Nr.::VE0023559
CAS-Nr.::287935-37-9
Summenformel::C18H23NO5
Molare Masse::333.4 g/mol

Zusätzliche Informationen zu CAS 287935-37-9

Parent drug

Salcaprozate

IUPAC-Name

Ethyl 8-(2, 4-dioxo-2H-benzo[e][1, 3]oxazin-3(4H)-yl)octanoate

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

O=C(OCC)CCCCCCCN1C(OC2=CC=CC=C2C1=O)=O

InChI

InChI=1S/C18H23NO5/c1-2-23-16(20)12-6-4-3-5-9-13-19-17(21)14-10-7-8-11-15(14)24-18(19)22/h7-8, 10-11H, 2-6, 9, 12-13H2, 1H3

Beschreibung

The Salcaprozate Impurity 3 standard is a well-characterized compound that aligns with key regulatory guidelines | including USP | EMA | JP | and BP. It plays a crucial role in analytical method development | method validation (AMV) | and quality control (QC) processes | particularly in the manufacturing of Salcaprozate. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | ensuring reliable and precise analytical outcomes. To further support research and development | it comes with a comprehensive Structure Elucidation Report (SER) | providing detailed insights for advanced analysis.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url